FDA Drug Recalls

Recalls / Class I

Class ID-020-2013

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1312-30, Barcode (01) 1 030409 131230 9 (carton), (01) 0 030409 131230 2 (cartridge unit).

Brand name
Hydromorphone Hydrochloride
Generic name
Hydromorphone Hydrochloride
Active ingredient
Hydromorphone Hydrochloride
Route
Intramuscular, Intravenous, Subcutaneous
NDCs
0409-1283, 0409-2552, 0409-3356, 0409-2540, 0409-3365, 0409-1312, 0409-1304
FDA application
NDA200403
Affected lot / code info
Lot 12720LL, Exp 12/01/13

Why it was recalled

Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
275 N Field Dr, N/A, Lake Forest, Illinois 60045-2579

Distribution

Quantity
216,880 cartridge units
Distribution pattern
Nationwide

Timeline

Recall initiated
2012-08-15
FDA classified
2012-10-24
Posted by FDA
2012-10-31
Terminated
2015-05-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-020-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.